WARPTECHNEWS · LAB

Home AI Business Tech Archive

Novo Nordisk sues Hims & Hers over copycat weight-loss drugs — Warptech Lab News

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

Shares in US company fall 16% after FDA announces investigation into unregulated medication

lunedì 9 febbraio 2026 New tab

Other newsrooms on this story

· 5 sources

Full timeline →

cnbc.com·Feb 6, 2026 · 6 mesi fa
Hims & Hers falls 8% after Novo's legal threat. Here's the latest
cnbc.com·Feb 9, 2026 · 6 mesi fa
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill
cnbc.com·Feb 5, 2026 · 6 mesi fa
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
cnbc.com·Feb 9, 2026 · 6 mesi fa
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
upi.com·Feb 9, 2026 · 6 mesi fa
Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

Related reading

Novo Nordisk hits out at rival Hims & Hers over cheaper weight-loss pill

US telehealth group will sell product for $49 a month, a third that of its Danish competitor

ft.com·6 mesi fa

Hims & Hers abandons copycat weight-loss drug in face of FDA probe

Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy

ft.com·6 mesi fa

Novo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs…

Danish group’s challenges mount despite winning reprieve after Hims & Hers withdraws plan to sell copycat Wegovy pill

ft.com·6 mesi fa

Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments

ft.com·1 anno fa

Hims shares shoot up after weight-loss drug deal with Novo Nordisk

US telehealth group and Danish drugmaker have been in dispute over copycat medicines

ft.com·5 mesi fa

Novo Nordisk calls for US import ban on key ingredient for obesity drug copycats

Danish group loses share in diabetes drugs to rivals, with first-half sales growth easing to 8%

ft.com·1 anno fa